Embody Biosciences
Develops a digital twin platform focused on brain health and neurodegeneration to support precision medicine and biopharmaceutical R&D. Platform capabilities emphasize causal systems physiology modeling, probabilistic machine learning, multi‑omics data integration, decision‑analytic integration, and individual‑patient mechanism‑of‑action assessment. Partners with industry and academic groups for multiomic data science and translational research.
Industries
Nr. of Employees
small (1-50)
Products
Brain health and neurodegeneration digital twin platform
A software platform that models individual brain physiology and disease trajectories using causal systems models, Bayesian machine learning, and multi‑omics integration to support precision medicine and biopharma R&D.
Brain health and neurodegeneration digital twin platform
A software platform that models individual brain physiology and disease trajectories using causal systems models, Bayesian machine learning, and multi‑omics integration to support precision medicine and biopharma R&D.
Services
Collaborative multiomic data science and translational partnerships
Partnership engagements with industry and academic groups to apply multi‑omic integration, modeling, and translational analytics to neurodegenerative research.
Collaborative multiomic data science and translational partnerships
Partnership engagements with industry and academic groups to apply multi‑omic integration, modeling, and translational analytics to neurodegenerative research.
Expertise Areas
- Digital twin modeling for neurological disease
- Multi‑omics integration and analysis
- Bayesian and probabilistic machine learning
- Translational mechanism‑of‑action assessment
Key Technologies
- Digital twin platforms
- Causal systems physiology modeling
- Bayesian machine learning
- Multi‑omics data integration